English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Plus

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Zendy Tools

Zendy Open

The conversion of the cellular isoform of the prion protein (PrP C ) into the pathologic isoform (PrP Sc ) is the key event in prion diseases. To study the conversion process, an  in vitro  system based on varying the concentration of low amounts of sodium dodecyl sulfate (SDS) has been employed. In the present study, the conversion of full-length PrP C  isolated from Chinese hamster ovary cells (CHO-PrP C ) was examined. CHO-PrP C  harbors native, posttranslational modifications, including the GPI anchor and two N-linked glyco-sylation sites. The properties of CHO-PrP C  were compared with those of full-length and N-terminally truncated recombinant PrP. As shown earlier with recombinant PrP (recPrP90-231), transition from a soluble α-helical state as known for native PrP C  into an aggregated, β-sheet-rich PrP Sc -like state could be induced by dilution of SDS. The aggregated state is partially proteinase K (PK)-resistant, exhibiting a cleavage site similar to that found with PrP Sc . Compared to recPrP (90-231), fibril formation with CHO-PrP C  requires lower SDS concentrations (0.0075%), and can be drastically accelerated by seeding with PrP Sc  purified from brain homogenates of terminally sick hamsters. Our results show that recPrP 90-231 and CHO-PrPC behave qualitatively similar but quantitatively different. The  in vivo  situation can be simulated closer with CHO-PrP C  because the specific PK cleave site could be shown and the seed-assisted fibrillization was much more efficient.

In vitro conversion and seeded fibrillization of posttranslationally modified prion protein